Ase: a randomised, double-blind, placebo-controlled trial. Lancet. 2017.miRNAs which can discriminate AD from controls. Here
Ase: a randomised, double-blind, placebo-controlled trial. Lancet. 2017.miRNAs which can discriminate AD from controls. Here we analyse the expression of AD-specific miRNAs inside a new and independent cohort of CSF…